Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs Prudential Financial Inc (PRU) Price & Performance

Ginkgo Bioworks Holdings IncTrade
Prudential Financial IncTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Prudential Financial Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.41 (market cap $505.73M), while Prudential Financial Inc trades at $122.31 (market cap $42.20B). The key difference: Prudential Financial Inc is far larger — about 83.4× Ginkgo Bioworks Holdings Inc's market cap, and Prudential Financial Inc pays a 4.58% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.

DNAPRU
Market Cap
$505.73M$42.20B
Sector
HealthFinancials
52-Week High
$16.14$123.93
52-Week Low
$5.48$92.00
Enterprise Value
$607.68M$70.98B
Dividend Yield
4.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $7.29, down 4.71% with bearish technical signals. The company reported Q2 2026 revenue of $20 million, down 48% year-over-year, continuing its strategic pivot to autonomous labs. Despite beating EPS expectations in two of the last three quarters, DNA shows negative profitability with -219.6% net income margin and negative cash flow. Analyst sentiment is mixed with 45% buy ratings but significant institutional selling pressure.

DNA faces substantial execution risk during its business transition, with declining revenue and persistent losses offset by potential in autonomous laboratory technology. The stock's current valuation at 3.61x sales appears stretched given negative earnings, requiring successful operational turnaround for sustainable recovery. Near-term catalysts depend on revenue stabilization and cost management improvements.

Prudential Financial Inc

Prudential Financial (PRU) trades at $122.11, up 0.68% today, with a bullish technical signal and strong Q2 2026 earnings beats. The stock shows solid fundamentals with a P/E of 11.09, ROE of 12.46%, and a $1.40 quarterly dividend. Recent news highlights strategic growth in wealth management and PGIM strength, though China tax concerns caused volatility.

Outlook is cautiously positive given earnings momentum and capital-light strategy, but risks include regulatory uncertainty in China and mixed analyst sentiment with 67.57% hold ratings. The consensus price target of $113.11 suggests limited upside from current levels, requiring monitoring of international operations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA

About Prudential Financial Inc

Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.

Read more on PRU